Has Roopen Patel, MD received payments from drug or device companies?

Yes. Drug and device makers reported $390,523 in general payments to Roopen Patel, MD across 1,051 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Roopen Patel, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Roopen Patel, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Roopen Patel, MD

Allergy & Immunology · Charlotte, NCNPI 1528145224

Payments from drug & device makers

$390,523in general payments, 2019–2025

Across 1,051 payments — averaging $371.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Sanofi US Services Inc.$123K
Regeneron Healthcare Solutions, Inc.$81K
Sanofi$68K
GSK$47K
Lilly USA, LLC$28K
AstraZeneca$18K
plus $28K from 38 others

$8,534in research payments, 2019–2025

Across 4 payments — averaging $2133.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Sanofi US Services Inc.$9K

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Sanofi US Services Inc.	50	$122,584
Regeneron Healthcare Solutions, Inc.	177	$80,915
Sanofi	109	$67,585
GSK	147	$46,821
Lilly USA, LLC	22	$27,600
AstraZeneca	175	$17,504
Regeneron	6	$11,471
Amgen	19	$2,778
Alk-abello, Inc	8	$2,605
Dermavant Sciences, Inc.	1	$1,640
Pfizer	57	$1,109
Arcutis Biotherapeutics, Inc.	1	$1,100
Novartis	41	$977
Takeda Pharmaceuticals U.S.A., Inc.	31	$706
CSL Behring	27	$650
Kaleo, Inc.	25	$456
Genentech USA, Inc.	26	$452
Grifols USA, LLC	21	$388
Optinose US, Inc.	17	$380
Octapharma USA, Inc.	7	$371
Organon	3	$266
ARS Pharmaceuticals Operations, Inc.	10	$248
Biocryst US Sales Co., LLC	9	$243
Pharming Healthcare, Inc.	7	$241
Phadia US Inc.	3	$176
AbbVie	8	$155
LEO Pharma Inc.	2	$147
Teva Pharmaceuticals USA, Inc.	7	$133
Circassia Inc.	2	$118
Sanofi-aventis U.S. LLC	3	$78
Boehringer Ingelheim	4	$78
Jubilant Hollisterstier LLC	1	$76
Hikma Pharmaceuticals USA	4	$72
Aytu Biopharma, Inc.	5	$69
Ionis Pharmaceuticals, Inc.	2	$57
Covis Pharma GmbH	3	$51
GC Biopharma USA, Inc.	2	$44
Galderma Laboratories, L.p.	2	$36
Shire North American Group Inc	2	$31
Siemens Medical Solutions USA, Inc.	1	$28
ADMA Biomanufacturing LLC	1	$22
Aimmune Therapeutics, Inc.	1	$22
Incyte Corporation	1	$19
Philips North America LLC	1	$19

How this compares

$390,523 in reported general payments places this provider in the 90th percentile of 140 allergy & immunology providers in North Carolina.

See all allergy & immunology providers in North Carolina →

Medicare billing

Part B allowed, 2024

$500,523

Medicare patients

210

Services billed

21,798

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other allergy & immunology in Charlotte

Maeve OconnorCharlotte$2.2M
John NorrisCharlotte$198K
Jennifer CaicedoCharlotte$174K
Vandana PatelCharlotte$105K
Richard CollinsCharlotte$28K
Shannon ChadhaCharlotte$22K
Emily LangleyCharlotte$21K
Bailee GilchristCharlotte$20K
Susan HungnessCharlotte$17K
Michael LapuenteCharlotte$14K

See the full list for North Carolina →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →